Malaysia: Draft Guidance for Public Comment on Distribution Records (2nd Edition)

The Medical Device Authority (MDA) has published the draft MDA/GD/0012 – Distribution Records (2nd Edition) for public comment.

The revised draft provides further clarification on the requirements for maintaining distribution records for medical devices placed on the Malaysian market, with additional emphasis on traceability, record control, and the responsibilities of establishments.

A key proposed change relates to implantable medical devices, where enhanced traceability requirements include tracking at the healthcare facility and patient level.

Read the MDA announcement here:
https://portal.mda.gov.my/index.php/announcement/1874-announcement-public-comment-second-edition-guidance-document-distribution-records

Purpose of the Draft Guidance

To provide updated guidance on the establishment, maintenance, retention, and control of distribution records for medical devices placed on the Malaysian market.

The proposed revisions also strengthen traceability requirements and clarify the responsibilities of establishments involved in medical device distribution.

Key Updates

1. Scope of Distribution Records

The draft further clarifies the scope and requirements for distribution records covering medical devices placed on the market.

Establishments should maintain appropriate records to support traceability throughout the distribution chain.

2. Additional Regulatory Definitions

The draft introduces or clarifies several definitions relevant to distribution record requirements, including:

  • Distributor
  • Establishment
  • Field Corrective Action (FCA)
  • Unique Device Identification (UDI)

3. Distribution Record Requirements

Further clarification is provided on the:

  • Content of distribution records
  • Maintenance of records
  • Record retention
  • Control of distribution records

The proposed requirements are intended to support more consistent and complete documentation of medical device distribution activities.

4. Enhanced Traceability for Implantable Medical Devices

The draft introduces enhanced traceability expectations for implantable medical devices.

Distribution records for affected devices are expected to support tracking at:

  • Healthcare facility level
  • Patient level

This is intended to strengthen traceability and support post-market activities where affected devices need to be identified or located.

5. Establishment Responsibilities

The draft further clarifies that establishments are responsible for establishing, maintaining, and complying with appropriate distribution record requirements.

Implications to Clients

Foreign Manufacturers and Product Owners should ensure that their appointed Malaysian importers and distributors maintain complete and up-to-date distribution records in accordance with applicable requirements.

Local importers and distributors should review the proposed guidance and assess whether their current systems can support the updated requirements, particularly in relation to:

  • Record completeness and retention
  • Traceability throughout the distribution chain
  • Healthcare facility and patient-level tracking for implantable medical devices
  • FCA and post-market activities
  • UDI-related information, where applicable

As the document remains in draft form, the proposed changes should not yet be treated as final requirements.

Public Comment

Stakeholders are encouraged to review the draft and provide feedback directly to MDA: Public Comment Form. (PDF)

Public Comment Period: 3–18 November 2026

Submission Email: guidancedocument@mda.gov.my

Effective Date

Not yet applicable.

The document is currently issued for public comment. Final requirements will apply following publication of the finalized guidance by MDA.

For Inquiries

For inquiries or support regarding medical device regulatory requirements in Malaysia, please contact sales@andamanmed.com.

Sign up for our regulatory roundup delivered once a month to your inbox

Scroll to Top

Contact Us

Contact Form Demo